Published in Mol Cell Biol on November 01, 1992
Transcriptional regulation of CLN3 expression by glucose in Saccharomyces cerevisiae. J Bacteriol (1998) 1.86
Hypoxia reprograms calcium signaling and regulates myoglobin expression. Am J Physiol Cell Physiol (2008) 1.69
ZBP-89, a Krüppel-like zinc finger protein, inhibits epidermal growth factor induction of the gastrin promoter. Mol Cell Biol (1996) 1.39
Transient expression of a winged-helix protein, MNF-beta, during myogenesis. Mol Cell Biol (1997) 1.36
Synergistic interactions between heterologous upstream activation elements and specific TATA sequences in a muscle-specific promoter. Mol Cell Biol (1995) 1.32
An E box mediates activation and repression of the acetylcholine receptor delta-subunit gene during myogenesis. Mol Cell Biol (1993) 1.29
Transcription enhancer factor 1 binds multiple muscle MEF2 and A/T-rich elements during fast-to-slow skeletal muscle fiber type transitions. Mol Cell Biol (2003) 1.23
Regulation of the human cardiac/slow-twitch troponin C gene by multiple, cooperative, cell-type-specific, and MyoD-responsive elements. Mol Cell Biol (1993) 1.22
Identification of a novel slow-muscle-fiber enhancer binding protein, MusTRD1. Mol Cell Biol (1998) 1.17
Myocyte nuclear factor, a novel winged-helix transcription factor under both developmental and neural regulation in striated myocytes. Mol Cell Biol (1994) 1.15
Common core sequences are found in skeletal muscle slow- and fast-fiber-type-specific regulatory elements. Mol Cell Biol (1996) 1.08
Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins. Nucleic Acids Res (2001) 1.04
Gradients of transgene expression directed by the human myoglobin promoter in the developing mouse heart. Proc Natl Acad Sci U S A (1993) 1.00
Transcription of the human beta enolase gene (ENO-3) is regulated by an intronic muscle-specific enhancer that binds myocyte-specific enhancer factor 2 proteins and ubiquitous G-rich-box binding factors. Mol Cell Biol (1995) 0.96
Identification and characterisation of two transcriptional repressor elements within the coding sequence of the Saccharomyces cerevisiae HXK2 gene. Nucleic Acids Res (1996) 0.94
Multiple non-collinear TF-map alignments of promoter regions. BMC Bioinformatics (2007) 0.86
Disruption of MEF2C signaling and loss of sarcomeric and mitochondrial integrity in cancer-induced skeletal muscle wasting. Aging (Albany NY) (2012) 0.84
Molecular Analysis of a Recurrent Sarcoma Identifies a Mutation in FAF1. Sarcoma (2015) 0.81
Functional analysis of the human annexin A5 gene promoter: a downstream DNA element and an upstream long terminal repeat regulate transcription. Biochem J (2001) 0.80
The LIM domain protein nTRIP6 acts as a co-repressor for the transcription factor MEF2C in myoblasts. Sci Rep (2016) 0.75
A 27 kDa protein binds to a positive and a negative regulatory sequence in the promoter of the ICL1 gene from Saccharomyces cerevisiae. Biochem J (1998) 0.75
Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol (1987) 26.70
Electroporation for the efficient transfection of mammalian cells with DNA. Nucleic Acids Res (1987) 12.80
Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell (1987) 12.30
Homeobox genes and axial patterning. Cell (1992) 12.03
The myoD gene family: nodal point during specification of the muscle cell lineage. Science (1991) 9.53
Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science (1986) 8.01
MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer. Cell (1989) 6.94
Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J Cell Biol (1982) 5.52
A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes. Mol Cell Biol (1989) 4.72
Use of a protein-blotting procedure and a specific DNA probe to identify nuclear proteins that recognize the promoter region of the transferrin receptor gene. Proc Natl Acad Sci U S A (1985) 3.91
Expression of two myogenic regulatory factors myogenin and MyoD1 during mouse embryogenesis. Nature (1989) 3.73
Cooperativity of the glucocorticoid receptor and the CACCC-box binding factor. Nature (1988) 3.69
Muscle-specific expression of the cardiac alpha-actin gene requires MyoD1, CArG-box binding factor, and Sp1. Genes Dev (1990) 3.62
The human beta-globin promoter; nuclear protein factors and erythroid specific induction of transcription. EMBO J (1988) 3.16
Murine developmental control genes. Science (1990) 2.71
Molecular cloning and characterization of mutant and wild-type human beta-actin genes. Mol Cell Biol (1984) 2.41
Myogenin induces the myocyte-specific enhancer binding factor MEF-2 independently of other muscle-specific gene products. Mol Cell Biol (1991) 2.40
Two adjacent MyoD1-binding sites regulate expression of the acetylcholine receptor alpha-subunit gene. Nature (1990) 2.39
Functional heterogeneity of mammalian TATA-box sequences revealed by interaction with a cell-specific enhancer. Nature (1990) 2.27
MyoD expression in the forming somites is an early response to mesoderm induction in Xenopus embryos. EMBO J (1989) 2.16
Paired MyoD-binding sites regulate myosin light chain gene expression. Proc Natl Acad Sci U S A (1991) 2.14
Cross-binding of factors to functionally different promoter elements in c-fos and skeletal actin genes. Mol Cell Biol (1989) 1.94
M-CAT binding factor, a novel trans-acting factor governing muscle-specific transcription. Mol Cell Biol (1990) 1.74
The upstream muscle-specific enhancer of the rat muscle creatine kinase gene is composed of multiple elements. Mol Cell Biol (1989) 1.73
A ubiquitous factor (HF-1a) and a distinct muscle factor (HF-1b/MEF-2) form an E-box-independent pathway for cardiac muscle gene expression. Mol Cell Biol (1992) 1.61
Organization of the human myoglobin gene. EMBO J (1984) 1.49
A MyoD1-independent muscle-specific enhancer controls the expression of the beta-myosin heavy chain gene in skeletal and cardiac muscle cells. J Biol Chem (1991) 1.46
The seal myoglobin gene: an unusually long globin gene. Nature (1983) 1.44
Differential patterns of transcript accumulation during human myogenesis. Mol Cell Biol (1987) 1.39
Developmental patterns in the expression of Myf5, MyoD, myogenin, and MRF4 during myogenesis. New Biol (1991) 1.32
The CACC box upstream of human embryonic epsilon globin gene binds Sp1 and is a functional promoter element in vitro and in vivo. J Biol Chem (1991) 1.31
Identification and characterization of a cardiac-specific transcriptional regulatory element in the slow/cardiac troponin C gene. Mol Cell Biol (1992) 1.23
Identification of a muscle-specific enhancer within the 5'-flanking region of the human myoglobin gene. J Biol Chem (1989) 1.19
Functional activity of the two promoters of the myosin alkali light chain gene in primary muscle cell cultures: comparison with other muscle gene promoters and other culture systems. Nucleic Acids Res (1988) 1.15
The mouse myoglobin gene. Characterisation and sequence comparison with other mammalian myoglobin genes. Eur J Biochem (1986) 1.02
Muscle-specific regulation of a transfected rabbit myosin heavy chain beta gene promoter. J Biol Chem (1989) 0.98
Pretranslational regulation of myoglobin gene expression. Am J Physiol (1987) 0.92
Myoglobin expression: early induction and subsequent modulation of myoglobin and myoglobin mRNA during myogenesis. Mol Cell Biol (1986) 0.91
A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev (1998) 5.14
Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers. Antimicrob Agents Chemother (1984) 4.03
MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type. EMBO J (2000) 3.59
E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev (1998) 3.48
Cytochrome c deficiency causes embryonic lethality and attenuates stress-induced apoptosis. Cell (2000) 3.39
A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J Biol Chem (2000) 3.26
Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo. J Biol Chem (2000) 3.19
Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ Res (2000) 3.04
Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A (2001) 2.64
Presentation of midgut malrotation in adults. Br Med J (1968) 2.56
Structure of a conjugating enzyme-ubiquitin thiolester intermediate reveals a novel role for the ubiquitin tail. Structure (2001) 2.48
Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells. Proc Natl Acad Sci U S A (1998) 2.40
Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway. EMBO J (2001) 2.38
Functional heterogeneity of mammalian TATA-box sequences revealed by interaction with a cell-specific enhancer. Nature (1990) 2.27
Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. Science (1985) 2.23
Calcineurin signaling and muscle remodeling. Cell (2000) 2.22
Regulation of stroke volume during submaximal and maximal upright exercise in normal man. Circ Res (1986) 2.15
Complete Sequence and Enhancer Function of the Homologous DNA Regions of Autographa californica Nuclear Polyhedrosis Virus. J Virol (1986) 2.14
The Growth of Various Species of Bacteria and Other Micro-Organisms in Atmospheres Enriched with Oxygen. Biochem J (1911) 2.06
Web sites selling cigarettes: how many are there in the USA and what are their sales practices? Tob Control (2001) 2.06
Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization. Nature (1984) 2.02
The fascinating history of bezoars. Med J Aust (1987) 1.96
Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Ann Rheum Dis (2010) 1.86
Achieving consistency in the lateral nasal osteotomy during rhinoplasty: an external perforated technique. Plast Reconstr Surg (2001) 1.84
Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy. Proc Natl Acad Sci U S A (2003) 1.84
Physical conditioning augments the fibrinolytic response to venous occlusion in healthy adults. N Engl J Med (1980) 1.81
Mice without myoglobin. Nature (1998) 1.78
Regulation of nuclear and mitochondrial gene expression by contractile activity in skeletal muscle. J Biol Chem (1986) 1.78
Repeat polymorphisms within gene regions: phenotypic and evolutionary implications. Am J Hum Genet (2000) 1.75
Cardiac-specific LIM protein FHL2 modifies the hypertrophic response to beta-adrenergic stimulation. Circulation (2001) 1.74
The Growth of the Bacillus tuberculosis and other Micro-Organisms in Varying Percentages of Oxygen. Biochem J (1909) 1.72
Myogenic stem cell function is impaired in mice lacking the forkhead/winged helix protein MNF. Proc Natl Acad Sci U S A (2000) 1.68
The passage of Florida's Statute on Assisted Reproductive Technology. Obstet Gynecol (1994) 1.66
Remodeling muscles with calcineurin. Bioessays (2000) 1.66
A prospective study of Alzheimer disease in Down syndrome. Arch Neurol (1989) 1.64
Management of Meckel's diverticulum. Br J Surg (1981) 1.61
Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med (1990) 1.60
Subcellular partitioning of MRP RNA assessed by ultrastructural and biochemical analysis. J Cell Biol (1994) 1.54
Colour Changes produced by two groups of Bacteria upon Caseinogen and certain Amino-acids. Biochem J (1917) 1.53
Mitochondrial gene expression in mammalian striated muscle. Evidence that variation in gene dosage is the major regulatory event. J Biol Chem (1986) 1.51
Cardiovascular and behavioral effects of aerobic exercise training in healthy older men and women. J Gerontol (1989) 1.51
Multiple-dose pharmacokinetics of ciprofloxacin administered intravenously to normal volunteers. Antimicrob Agents Chemother (1985) 1.46
Exercise training in healthy type A middle-aged men: effects on behavioral and cardiovascular responses. Psychosom Med (1988) 1.45
Alzheimer's disease presenting as slowly progressive aphasia. R I Med J (1984) 1.43
A multiple-dose pharmacokinetic comparison of naproxen as a once-daily controlled-release tablet and a twice-daily conventional tablet. J Clin Pharmacol (1987) 1.40
The RASSF1A isoform of RASSF1 promotes microtubule stability and suppresses tumorigenesis. Mol Cell Biol (2005) 1.40
Comparison of high- and low-intensity exercise training early after acute myocardial infarction. Am J Cardiol (1988) 1.39
Dietary protein, growth and retention of ascorbic acid in guinea-pigs. Br J Nutr (1972) 1.39
Relative bioavailability of a new transdermal nitroglycerin delivery system. J Pharm Sci (1986) 1.39
A retrospective analysis comparing the costs and cost effectiveness of amlodipine and enalapril in the treatment of hypertension. Manag Care Interface (2001) 1.38
Induction of stress proteins in cultured myogenic cells. Molecular signals for the activation of heat shock transcription factor during ischemia. J Clin Invest (1992) 1.37
From genome to vaccine: in silico predictions, ex vivo verification. Vaccine (2001) 1.37
Out-patient letters: requirement and contents. Eff Health Care (1985) 1.37
Activation of the heat shock transcription factor by hypoxia in mammalian cells. Proc Natl Acad Sci U S A (1990) 1.36
Physiological and psychological variables predict compliance to prescribed exercise therapy in patients recovering from myocardial infarction. Psychosom Med (1982) 1.36
Transient expression of a winged-helix protein, MNF-beta, during myogenesis. Mol Cell Biol (1997) 1.36
Cerebro-ocular dysgenesis (Walker-Warburg syndrome): neuropathologic and etiologic analysis. Neurology (1984) 1.36
PR48, a novel regulatory subunit of protein phosphatase 2A, interacts with Cdc6 and modulates DNA replication in human cells. Mol Cell Biol (2000) 1.36
Persistent expression of MNF identifies myogenic stem cells in postnatal muscles. Dev Biol (1997) 1.35
Direct characterization of methanogens in two high-rate anaerobic biological reactors. Appl Environ Microbiol (1988) 1.34
Cardioprotective effects of 70-kDa heat shock protein in transgenic mice. Proc Natl Acad Sci U S A (1996) 1.32
Methods for reducing non-specific antibody binding in enzyme-linked immunosorbent assays. J Immunol Methods (1985) 1.32
Synergistic interactions between heterologous upstream activation elements and specific TATA sequences in a muscle-specific promoter. Mol Cell Biol (1995) 1.32
Morphometric analysis of the prefrontal cortex in Huntington's disease. Neurology (1991) 1.30
Radioiodination of botulinum neurotoxin type A with retention of biological activity and its binding to brain synaptosomes. Eur J Biochem (1983) 1.25
Rupture of spleen at colonoscopy. Br Med J (1979) 1.24
Cloning and characterization of a eukaryotic pantothenate kinase gene (panK) from Aspergillus nidulans. J Biol Chem (1999) 1.24
Exercise responses before and after physical conditioning in patients with severely depressed left ventricular function. Am J Cardiol (1982) 1.23
Changing strategies in the performance of laparoscopic Nissen fundoplication as a result of experience with 230 operations. Surg Endosc (1995) 1.22
Transport of proteins into chloroplasts. Organization, orientation, and lateral distribution of the plastocyanin processing peptidase in the thylakoid network. J Biol Chem (1988) 1.22
Translocation of zinc may contribute to seizure-induced death of neurons. Brain Res (1989) 1.22
The Golgi rapid method in clinical neuropathology: the morphologic consequences of suboptimal fixation. J Neuropathol Exp Neurol (1978) 1.20
Autism and mental retardation: neuropathologic studies performed in four retarded persons with autistic behavior. Arch Neurol (1980) 1.19
Adaptation of skeletal muscle to increased contractile activity. Expression nuclear genes encoding mitochondrial proteins. J Biol Chem (1987) 1.19
Identification of a muscle-specific enhancer within the 5'-flanking region of the human myoglobin gene. J Biol Chem (1989) 1.19
The cellular pathology of Menkes steely hair syndrome. Neurology (1978) 1.19
Botulinum neurotoxin and dendrotoxin as probes for studies on transmitter release. J Physiol (Paris) (1984) 1.19
The winged-helix/forkhead protein myocyte nuclear factor beta (MNF-beta) forms a co-repressor complex with mammalian sin3B. Biochem J (2000) 1.18
Evaluation of orally administered highly variable drugs and drug formulations. Pharm Res (1996) 1.17
Botulinum neurotoxin type B. Its purification, radioiodination and interaction with rat-brain synaptosomal membranes. Eur J Biochem (1986) 1.17
Age-related changes in the density and morphology of plaques and neurofibrillary tangles in Down syndrome brain. Acta Neuropathol (1989) 1.16
Effect of phenobarbital on theophylline disposition. J Allergy Clin Immunol (1978) 1.16
Electrical stimulation of neonatal cardiac myocytes activates the NFAT3 and GATA4 pathways and up-regulates the adenylosuccinate synthetase 1 gene. J Biol Chem (2000) 1.15
Sex-linked hereditary bilateral anophthalmos. Pathologic and radiologic correlation. Arch Ophthalmol (1984) 1.15
Myocyte nuclear factor, a novel winged-helix transcription factor under both developmental and neural regulation in striated myocytes. Mol Cell Biol (1994) 1.15
Characterization of the glycosylation sites in yeast external invertase. I. N-linked oligosaccharide content of the individual sequons. J Biol Chem (1988) 1.15
The assembly of immunoglobulin-like modules in titin: implications for muscle elasticity. J Mol Biol (1998) 1.15
Effects of GnRH analogues, 'add-back' steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-beta expression. Mol Hum Reprod (2002) 1.13
The cellular pathology of neuronal ceroid-lipofuscinosis. A golgi-electronmicroscopic study. Arch Neurol (1977) 1.10
Scaleup of immediate release oral solid dosage forms. Pharm Res (1993) 1.10
Skeletal muscle beta-adrenergic receptors: variations due to fiber type and training. Am J Physiol (1984) 1.09
Differential expression of mitochondrial DNA replication factors in mammalian tissues. J Biol Chem (1998) 1.09
Continuous contractile activity induces fiber type specific expression of HSP70 in skeletal muscle. Am J Physiol (1996) 1.08
The Viability of B. tuberculosis (bovinus) on Pasture Land, in Stored Faeces and in Liquid Manure. J Hyg (Lond) (1930) 1.07
Mitochondrial biogenesis in striated muscles: rapid induction of citrate synthase mRNA by nerve stimulation. Am J Physiol (1991) 1.07
Characterization of the biochemical properties of recombinant ribonuclease III. Nucleic Acids Res (1990) 1.07
Postnatal development and plasticity of specialized muscle fiber characteristics in the hindlimb. Dev Genet (1996) 1.07